Quarterly report pursuant to Section 13 or 15(d)

Statements of Cash Flows

v3.20.2
Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Loss from continuing operations $ (6,658,498) $ (2,328,138)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 86,368 82,913
Write-off of capitalized patents 18,235 0
Stock-based compensation 434,782 156,882
Stock issued for services 50,000 0
Warrant inducement expense 3,720,866 0
Decrease in operating assets:    
Accounts receivable (28,623) 0
Prepayments and other current assets 127,632 204,530
Increase (decrease) in operating liabilities:    
Accounts payable (116,246) 1,337
Accrued expenses 61,845 6,336
Net cash used in operating activities (2,303,639) (1,876,140)
Net cash used in operating activities - discontinued operations 0 (557,096)
Cash flows from investing activities:    
Purchase of property and equipment (12,407) (4,253)
Acquisition of intangible assets (35,836) (74,342)
Net cash used in investing activities (48,243) (78,595)
Net cash provided by investing activities - discontinued operations 0 23,587
Cash flows from financing activities:    
Proceeds from loans 91,407 0
Proceeds from the exercise of warrants 2,972,018 0
Net cash provided by financing activities 3,063,425 0
Net increase (decrease) in cash and cash equivalents - continuing operations 711,543 (1,954,735)
Net decrease in cash and cash equivalents - discontinued operations 0 (533,509)
Cash and cash equivalents at beginning of period 3,057,682 3,258,077
Cash and cash equivalents at end of period $ 3,769,225 $ 769,833